“Today we can produce PLA directly from glucose, but in the future, we will obtain it starting from organic wastes and, looking more forward, from carbon dioxide”. To say it – in this interview with Il Bioeconomista – is Danilo Porro, professor at University of Milano Bicocca and President of Galatea Biotech, one of the most innovative Italian industrial biotech start-up company. Headquartered in Milan, Galatea has developed a new process to produce PLA from glucose.
Interview by Mario Bonaccorso
Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.
It’s awesome! The emergency is finally over. We can go back to our life. The virus was defeated without waiting for the vaccine, because we all behaved in the best way, staying at home and respecting the physical distance. Now we can go back to meet, talk to each other and, if necessary, also to hug. We’ll always remember all the dead people and the sufferings. And also the physicians and nurses and all the people who spent themselves on others.
IL BIOECONOMISTA 